GlassScriptPhysician profile
Amrit V Bhaskarla
NPI 1265965123
$1,000.64
in general payments reported to CMS, 2019-2025
25 companies · $14.13 in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $144 · 2021: $380 · 2022: $462 · 2025: $14.13.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $14.13.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $14.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $166.04 | 2020-2022 | |
| Amgen INC. | $100.91 | 2020-2022 | |
| Janssen Pharmaceuticals, INC | $92.73 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $66.62 | 2021-2022 | |
| Octapharma USA, INC. | $64.70 | 2022 | |
| Janssen Biotech, INC. | $43.25 | 2022 | |
| Daiichi Sankyo INC. | $39.49 | 2022 | |
| Dova Pharmaceuticals | $39.25 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $39.20 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $34.56 | 2021-2022 | |
| Myovant Sciences INC. | $27.86 | 2021 | |
| Abbvie INC. | $27.28 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $26.31 | 2021 | |
| Progenics Pharmaceuticals, INC. | $25.48 | 2022 | |
| Pharmacyclics LLC, An Abbvie Company | $24.16 | 2020 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Adc Therapeutics America, INC. | $22.38 | 2022 | |
| Jazz Pharmaceuticals INC. | $20.59 | 2021 | |
| Organon LLC | $19.79 | 2022 | |
| Global Blood Therapeutics, INC. | $18.98 | 2022 | |
| Puma Biotechnology, INC. | $18.04 | 2020 | |
| Genzyme Corporation | $17.65 | 2020 | |
| Ipsen Biopharmaceuticals, INC | $17.47 | 2022 | |
| Servier Pharmaceuticals LLC | $17.34 | 2022 | |
| Eisai INC. | $16.49 | 2021 | |
| Pfizer INC. | $14.07 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amrit Bhaskarla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.